| Literature DB >> 27183620 |
Byram W Bridle1, Andrew Nguyen2, Omar Salem2, Liang Zhang2, Sandeep Koshy2, Derek Clouthier2, Lan Chen2, Jonathan Pol2, Stephanie L Swift2, Dawn M E Bowdish2, Brian D Lichty2, Jonathan L Bramson2, Yonghong Wan3.
Abstract
Effector T cells (TEFF) are a barrier to booster vaccination because they can rapidly kill Ag-bearing APCs before memory T cells are engaged. We report in this study that i.v. delivery of rhabdoviral vectors leads to direct infection of follicular B cells in the spleen, where the earliest evidence of secondary T cell responses was observed. This allows booster immunizations to rapidly expand CD8(+) central memory T cells (TCM) during the acute phase of the primary response that is dominated by TEFF Interestingly, although the ablation of B cells before boosting with rhabdoviral vectors diminishes the expansion of memory T cells, B cells do not present Ags directly. Instead, depletion of CD11c(+) dendritic cells abrogates secondary T cell expansion, suggesting that virus-infected follicular B cells may function as an Ag source for local DCs to subsequently capture and present the Ag. Because TCM are located within B cell follicles in the spleen whereas TEFF cannot traffic through follicular regions, Ag production and presentation by follicular APCs represent a unique mechanism to secure engagement of TCM during an ongoing effector response. Our data offer insights into novel strategies for rapid expansion of CD8(+) T cells using prime-boost vaccines by targeting privileged sites for Ag presentation.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27183620 DOI: 10.4049/jimmunol.1600106
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422